Tenaya Therapeutics, Inc. (TNYA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 225K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 1.76M | -3.95M | 0 | 2.08M | 0 | 0 | 0 | 2.12M | 2.15M | 2.99M | 2.98M | 2.97M | 2.88M | 2.85M | 2.8M | 1.76M | 1.3M | 1.11M | 1.05M | 998K |
| COGS % of Revenue | 783.56% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -1.54M | 3.95M | 0 | -2.08M | 0 | 0 | 0 | -2.12M | -2.15M | -2.99M | -2.98M | -2.97M | -2.88M | -2.85M | -2.8M | -1.76M | -1.3M | -1.11M | -1.05M | -998K |
| Gross Margin % | -683.56% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | 1.84% | 100% | 100% | 100% | 28.54% | 25.28% | -4.7% | -6.25% | -68.81% | -122.19% | -156.56% | -165.59% | -76.35% | -88.39% | - | - | - |
| Operating Expenses | 18.53M | 24.72M | 20.94M | 22M | 27.54M | 24.65M | 26.71M | 28.7M | 31.61M | 28.46M | 27.94M | 32.13M | 30.84M | 31.7M | 28.5M | 26.86M | 29.86M | 25.05M | 17.25M | 14.24M |
| OpEx % of Revenue | 8234.22% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 5.45M | 5.98M | 5.57M | 6.71M | 6.46M | 5.96M | 6.36M | 6.05M | 6.55M | 5.59M | 4.85M | 5.66M | 5.23M | 5.95M | 4.74M | 5.98M | 5.7M | 4.1M | 4.3M | 3.33M |
| SG&A % of Revenue | 2420.89% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 14.84M | 14.8M | 15.36M | 17.37M | 21.08M | 18.69M | 20.35M | 22.65M | 25.05M | 22.86M | 23.09M | 26.48M | 25.61M | 25.75M | 23.76M | 20.88M | 24.16M | 20.95M | 12.94M | 10.91M |
| R&D % of Revenue | 6596.89% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -1000K | 1000K | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20.07M | -20.77M | -20.94M | -24.08M | -27.54M | -24.65M | -26.71M | -30.82M | -33.76M | -31.45M | -30.92M | -35.1M | -33.72M | -34.55M | -31.3M | -28.62M | -31.15M | -26.16M | -18.3M | -15.24M |
| Operating Margin % | -8917.78% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 27.14% | 15.73% | 21.62% | 21.87% | 18.43% | 21.61% | 13.61% | 12.2% | -0.12% | 8.98% | 1.21% | -22.66% | -8.25% | -32.05% | -71.03% | -87.83% | -137.73% | -153.48% | - | - |
| EBITDA | -18.3M | -18.95M | -19.07M | -22M | -24.88M | -22.56M | -24.61M | -28.7M | -31.61M | -28.46M | -27.94M | -32.13M | -30.84M | -31.7M | -28.5M | -26.86M | -29.86M | -25.05M | -17.25M | -14.24M |
| EBITDA Margin % | -8134.22% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 26.43% | 16.02% | 22.5% | 23.35% | 21.29% | 20.72% | 11.93% | 10.68% | -2.49% | 10.22% | 1.94% | -19.64% | -3.29% | -26.52% | -65.24% | -88.63% | -140.46% | -159.23% | - | - |
| D&A (Non-Cash Add-back) | 1.76M | 1.83M | 1.86M | 2.08M | 2.66M | 2.09M | 2.1M | 2.12M | 2.15M | 2.99M | 2.98M | 2.97M | 2.88M | 2.85M | 2.8M | 1.76M | 1.3M | 1.11M | 1.05M | 998K |
| EBIT | -20.07M | -20.77M | -20.94M | -23.28M | -27.54M | -24.65M | -26.71M | -29.43M | -32.23M | -29.93M | -29.14M | -33.27M | -31.74M | -33.52M | -30.7M | -28.4M | -31.06M | -26.15M | -18.26M | -15.21M |
| Net Interest Income | 793K | 574K | 658K | 815K | 635K | 812K | 1.08M | 1.39M | 1.45M | 1.47M | 1.78M | 1.84M | 1.97M | 1.04M | 596K | 222K | 99K | 67K | 23K | 9K |
| Interest Income | 793K | 574K | 658K | 815K | 635K | 812K | 1.08M | 1.39M | 1.45M | 1.47M | 1.78M | 1.84M | 1.97M | 1.04M | 596K | 222K | 99K | 67K | 23K | 9K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 793K | 600K | 661K | 799K | 674K | 816K | 1.08M | 1.39M | 1.53M | 1.51M | 1.78M | 1.83M | 1.99M | 1.03M | 602K | 222K | 98K | 13K | 38K | 27K |
| Pretax Income | -19.27M | -20.18M | -20.27M | -23.28M | -26.86M | -23.84M | -25.63M | -29.43M | -32.23M | -29.93M | -29.14M | -33.27M | -31.74M | -33.52M | -30.7M | -28.4M | -31.06M | -26.15M | -18.26M | -15.21M |
| Pretax Margin % | -8565.33% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -19.27M | -20.18M | -20.27M | -23.28M | -26.86M | -23.84M | -25.63M | -29.43M | -32.23M | -29.93M | -29.14M | -33.27M | -31.74M | -33.52M | -30.7M | -28.4M | -31.06M | -26.15M | -18.26M | -15.21M |
| Net Margin % | -8565.33% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 28.26% | 15.36% | 20.91% | 20.89% | 16.64% | 20.37% | 12.04% | 11.54% | -1.55% | 10.68% | 5.06% | -17.16% | -2.19% | -28.16% | -68.09% | -86.7% | -137.1% | -153.45% | - | - |
| Net Income (Continuing) | -19.27M | -20.18M | -20.27M | -23.28M | -26.86M | -23.84M | -25.63M | -29.43M | -32.23M | -29.93M | -29.14M | -33.27M | -31.74M | -33.52M | -30.7M | -28.4M | -31.06M | -26.15M | -18.26M | -15.21M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.09 | -0.12 | -0.12 | -0.14 | -0.24 | -0.28 | -0.30 | -0.34 | -0.40 | -0.44 | -0.39 | -0.45 | -0.43 | -0.62 | -0.73 | -0.68 | -0.75 | -0.63 | -0.68 | -0.41 |
| EPS Growth % | 62.5% | 57.14% | 60% | 58.82% | 40% | 36.36% | 23.08% | 24.44% | 6.98% | 29.03% | 46.58% | 33.82% | 42.67% | 1.59% | -7.35% | -65.85% | -56.25% | -65.79% | - | - |
| EPS (Basic) | -0.09 | -0.12 | -0.12 | -0.14 | -0.24 | -0.28 | -0.30 | -0.34 | -0.40 | -0.44 | -0.39 | -0.45 | -0.43 | -0.62 | -0.73 | -0.68 | -0.75 | -0.63 | -0.68 | -0.41 |
| Diluted Shares Outstanding | 152.97M | 152.97M | 163.35M | 162.79M | 109.87M | 86.41M | 86.16M | 85.71M | 80.98M | 68.33M | 73.92M | 73.4M | 73.1M | 55.25M | 41.36M | 41.3M | 41.27M | 41.25M | 26.9M | 37.32M |
| Basic Shares Outstanding | 152.97M | 152.97M | 163.35M | 162.79M | 109.87M | 86.41M | 86.16M | 85.71M | 80.98M | 68.33M | 73.92M | 73.4M | 73.1M | 55.25M | 41.36M | 41.3M | 41.27M | 41.25M | 26.9M | 37.32M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |